AuraSense Therapeutics, LLC

AuraSense Therapeutics, LLC

AuraSense Therapeutics, LLC

AuraSense Therapeutics is focused on the development and commercialization ofspherical nucleic acid conjugates.
Type
B2b
Founded
2009
Raised
$39M
Follow us
Alexa global traffic share
Latest funding Show all
$20,000,000
Venture capital (Series D) - 2017
AbbVie Biotech Ventures Eric Lefkofsky Craig Mundie +4
$13,600,000
Venture capital (Series C) - 2014
Bill Gates Boon Hwee Koh Craig Mundie +1
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when AuraSense Therapeutics, LLC makes some noise.